These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 7628161)
41. [Diagnosis of head and neck malignant tumors by scintigram using 67Ga-citrate (author's transl)]. Yoneyama M Nihon Jibiinkoka Gakkai Kaiho; 1978 Nov; 81(11):1422-31. PubMed ID: 366092 [No Abstract] [Full Text] [Related]
42. Usefulness of chest single photon emission computed tomography with technetium-99m methoxyisobutylisonitrile to predict taxol based chemotherapy response in advanced non-small cell lung cancer. Shih CM; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A Cancer Lett; 2003 Sep; 199(1):99-105. PubMed ID: 12963129 [TBL] [Abstract][Full Text] [Related]
43. Detection of late chest wall recurrence of breast carcinoma during Tc-99m sestamibi parathyroid scintigraphy. Conrad GR; Sloan DA; Sinha P Clin Nucl Med; 2003 May; 28(5):408-9. PubMed ID: 12702942 [No Abstract] [Full Text] [Related]
44. Scintimammographic findings of phyllodes tumor of the breast in a double-phase study with Tc-99m (V)DMSA and Tc-99m MIBI: a case report. Papantoniou V; Koutsikos J; Sotiropoulou M; Mainta E; Lazaris D; Tsiouris S; Zerva C Jpn J Clin Oncol; 2004 Jul; 34(7):429-31. PubMed ID: 15342672 [TBL] [Abstract][Full Text] [Related]
46. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy. Lind P; Gallowitsch HJ Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519 [TBL] [Abstract][Full Text] [Related]
48. Local recurrence of breast cancer demonstrated on 99mTc-MIBI scintigraphy. Katayama N; Inoue Y; Ichikawa T; Harada M; Itoh T; Shimoyamada K; Ikeda M; Tsukune Y; Yoshikawa K Radiat Med; 1999; 17(5):389-91. PubMed ID: 10593293 [TBL] [Abstract][Full Text] [Related]
49. [Scintigraphic functional diagnosis of the irradiated jaw bone in tumor therapy patients]. Kalz W; Buchali K; Dallüge KH; Marquardt P; Marquardt S; Sydow K Zahn Mund Kieferheilkd Zentralbl; 1990; 78(5):429-31. PubMed ID: 2150262 [No Abstract] [Full Text] [Related]
50. [Tc99m-sestamibi SPECT and head and neck tumors: preliminary data]. Galli J; Giordano A; Corina L; Maccafeo S; Cadoni G; D'Andrea G; Almadori G Acta Otorhinolaryngol Ital; 1999 Oct; 19(5):265-71. PubMed ID: 10827800 [TBL] [Abstract][Full Text] [Related]
51. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors. Preliminary results and comparison with Tl-201. Aktolun C; Bayhan H; Kir M Clin Nucl Med; 1992 Mar; 17(3):171-6. PubMed ID: 1611785 [TBL] [Abstract][Full Text] [Related]
52. Sarcomatous transformation of neurofibromas. Comparative imaging with Ga-67, Tl-201, Tc-99m pentavalent DMSA and Tc-99m MIBI. Lee J; Sohn SK; Ahn BC; Chun KA; Lee K; Kim CK Clin Nucl Med; 1997 Sep; 22(9):610-4. PubMed ID: 9298294 [TBL] [Abstract][Full Text] [Related]
53. F-18 FDG uptake by recurrent Hürthle cell carcinoma of the thyroid using high-energy planar scintigraphy. Blount CL; Dworkin HJ Clin Nucl Med; 1996 Nov; 21(11):831-3. PubMed ID: 8922841 [TBL] [Abstract][Full Text] [Related]
54. Comparison of technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography to detect recurrent or residual nasopharyngeal carcinomas after radiotherapy. Shiau YC; Tsai SC; Ho YJ; Kao CH Anticancer Res; 2001; 21(3C):2213-7. PubMed ID: 11501849 [TBL] [Abstract][Full Text] [Related]
55. [Tumor imaging using Tc(V)-99m dimercaptosuccinic acid, a newly developed radiopharmaceutical: its clinical usefulness]. Ohta H; Endo K; Koizumi M; Fujita T; Sakahara H; Nakashima T; Torizuka K; Hata N; Masuda H; Yomoda I Kaku Igaku; 1985 Nov; 22(11):1653-60. PubMed ID: 3007822 [No Abstract] [Full Text] [Related]
56. Tc-99m MIBI liver imaging for hepatocellular carcinoma: correlation with P-glycoprotein-multidrug-resistance gene expression. Chang CS; Yang SS; Yeh HZ; Kao CH; Chen GH Hepatogastroenterology; 2004; 51(55):211-4. PubMed ID: 15011866 [TBL] [Abstract][Full Text] [Related]
57. The promise FDG in diagnosis and surveillance of head and neck cancer. Mancuso AA; Drane WE; Mukherji SK Cancer; 1994 Aug; 74(4):1193-5. PubMed ID: 8055436 [No Abstract] [Full Text] [Related]
58. Tc-99m MIBI scintigraphy in patients with lung cancer. Comparison with CT and fluorine-18 FDG PET imaging. Wang H; Maurea S; Mainolfi C; Fiore F; Gravina A; Panico MR; Bazzicalupo L; Salvatore M Clin Nucl Med; 1997 Apr; 22(4):243-9. PubMed ID: 9099482 [TBL] [Abstract][Full Text] [Related]
59. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance. Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325 [TBL] [Abstract][Full Text] [Related]
60. Tc-99m sestamibi and other agents in the detection of metastatic medullary carcinoma of the thyroid. Lebouthillier G; Morais J; Picard M; Picard D; Chartrand R; D'Amour P Clin Nucl Med; 1993 Aug; 18(8):657-61. PubMed ID: 8403695 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]